These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 9010636)
1. Disposition and metabolism of finasteride in dogs. Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636 [TBL] [Abstract][Full Text] [Related]
2. Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. Carlin JR; Höglund P; Eriksson LO; Christofalo P; Gregoire SL; Taylor AM; Andersson KE Drug Metab Dispos; 1992; 20(2):148-55. PubMed ID: 1352203 [TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
4. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
5. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog. Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500 [TBL] [Abstract][Full Text] [Related]
6. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875 [TBL] [Abstract][Full Text] [Related]
7. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
10. Disposition of acrivastine in the male beagle dog. McNulty MJ; Deal DL; Nelson FR; Weller S; Chandrasurin P; Shockcor J; Findlay JW Drug Metab Dispos; 1992; 20(5):679-87. PubMed ID: 1358572 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog. Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
13. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
14. Physiological disposition and metabolism of timolol in man and laboratory animals. Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572 [TBL] [Abstract][Full Text] [Related]
16. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys. Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401 [TBL] [Abstract][Full Text] [Related]
17. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans. Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147 [TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
20. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]